Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diabetes therapy to improve BMI and pulmonary function in cystic fibrosis
2004-005019-28Phase 4Completed
- Sponsor
- Papworth Hospital NHS Foundation Trust
- Start
- Apr 2005
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of insulin aspart, repaglinide in cystic fibrosis-related diabetes (CFRD), cystic fibrosis (CF), sponsored by Papworth Hospital NHS Foundation Trust. Started Apr 2005; status: completed.
02
Drugs
insulin aspartrepaglinide
03
Conditions
cystic fibrosis-related diabetes (CFRD)cystic fibrosis (CF)
Beyond the preview
Go deeper on 2004-005019-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005019-28.